Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/04/1999 | WO1999055375A1 Stable mitoxantron solutions |
11/04/1999 | WO1999055374A1 Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
11/04/1999 | WO1999055373A1 Saccharide-containing compositions |
11/04/1999 | WO1999055372A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
11/04/1999 | WO1999055371A1 Solution containing nicotine |
11/04/1999 | WO1999055362A1 Spray dried formulations of igf-i |
11/04/1999 | WO1999055360A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
11/04/1999 | WO1999055353A2 Protein formulations |
11/04/1999 | WO1999055347A2 Treatment of papilloma virus infection using a mycobacterium |
11/04/1999 | WO1999055344A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
11/04/1999 | WO1999055342A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
11/04/1999 | WO1999055341A1 Transdermal administration of fenoldopam |
11/04/1999 | WO1999055338A1 Treatment of depression and pharmaceutical preparations therefor |
11/04/1999 | WO1999055337A1 Stabile compositions comprising levosimendan and alginic acid |
11/04/1999 | WO1999055333A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
11/04/1999 | WO1999055332A1 Medicinal compositions |
11/04/1999 | WO1999055327A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
11/04/1999 | WO1999055320A1 Oral formulation comprising biguanide and an organic acid |
11/04/1999 | WO1999055319A1 Aerosol formulations of salmeterol xinafoate |
11/04/1999 | WO1999055315A1 Periadventitial delivery device |
11/04/1999 | WO1999055314A1 Fibrinogen coated droplets of liquid hydrophobic phases |
11/04/1999 | WO1999055313A1 Pellets having a core coated with a lipid lowering agent and a polymer |
11/04/1999 | WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
11/04/1999 | WO1999055311A1 Tablets quickly disintegrated in oral cavity and process for producing the same |
11/04/1999 | WO1999055310A1 Stabilized protein crystals, formulations containing them and methods of making them |
11/04/1999 | WO1999055309A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
11/04/1999 | WO1999055308A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
11/04/1999 | WO1999055307A1 Method of treating the skin with organic acids in anhydrous polymeric delivery systems |
11/04/1999 | WO1999055306A1 Pharmaceutical composition comprising factor viii and neutral liposomes |
11/04/1999 | WO1999055305A2 Controlled release peroral compositions of levosimendan |
11/04/1999 | WO1999055304A1 Methods and compositions for stabilizing acetylcholine compositions |
11/04/1999 | WO1999055287A1 Topical anesthetic formulation |
11/04/1999 | WO1999055286A2 Drug-containing transdermal patches, plastisols and adhesives |
11/04/1999 | WO1999055285A2 Dilating and support apparatus with disease inhibitors and methods for use |
11/04/1999 | WO1999055171A1 Licking stone |
11/04/1999 | WO1999055158A1 S-rabeprazole compositions and methods |
11/04/1999 | WO1999055157A1 R-rabeprazole compositions and methods |
11/04/1999 | WO1999047543A3 Sustained-release composition including amorphous polymer |
11/04/1999 | WO1999043355A3 Formulations containing oxaliplatin |
11/04/1999 | WO1999043299A3 Oral formulation for hydrophilic drugs |
11/04/1999 | WO1999040921A3 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
11/04/1999 | WO1999040898A3 Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
11/04/1999 | DE19907764A1 Preparation of acid-resistant pancreatin granulates |
11/04/1999 | DE19709704C2 Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie Use of a liquid preparation for intravenous administration of xenon at the initiation and / or maintenance of anesthesia |
11/04/1999 | CA2367888A1 Herbal composition and medicament against diabetes mellitus type ii manufactured thereof |
11/04/1999 | CA2330934A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
11/04/1999 | CA2330644A1 Solution containing nicotine |
11/04/1999 | CA2330563A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
11/04/1999 | CA2330498A1 Non cross-linked block polyetherester, preparation and uses |
11/04/1999 | CA2330481A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
11/04/1999 | CA2330479A1 Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
11/04/1999 | CA2330476A1 Stabilized protein crystals, formulations containing them and methods of making them |
11/04/1999 | CA2330391A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
11/04/1999 | CA2330387A1 Treatment of papilloma virus infection using a mycobacterium |
11/04/1999 | CA2330324A1 S-rabeprazole compositions and methods |
11/04/1999 | CA2330139A1 R-rabeprazole compositions and methods |
11/04/1999 | CA2329900A1 Metered-dose valve for pharmaceutical aerosol |
11/04/1999 | CA2329762A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
11/04/1999 | CA2328970A1 Pellets having a core coated with a lipid lowering agent and a polymer |
11/04/1999 | CA2328165A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
11/04/1999 | CA2327469A1 Fibrinogen coated droplets of liquid hydrophobic phases |
11/04/1999 | CA2326114A1 Periadventitial delivery device |
11/04/1999 | CA2270670A1 Skin barrier composition |
11/03/1999 | EP0953630A1 Transesterification products of corn oil and glycerol and their use in pharmaceutical compositions |
11/03/1999 | EP0953362A2 Methods and apparatus for the delivery of solid drug compositions |
11/03/1999 | EP0953359A1 Pharmaceutical composition for oral administration |
11/03/1999 | EP0953358A1 Use of coplymers comprising N-Vinyllactam and/or N-Vinylamine as matrix for preparing solid pharmaceutical and/or application forms |
11/03/1999 | EP0953350A1 Extended release formulation of diltiazem hydrochloride |
11/03/1999 | EP0953348A1 Patch with adhesive matrix |
11/03/1999 | EP0953347A2 Use of graft polymers containing polyalkyleneoxides as solubilizers |
11/03/1999 | EP0953342A2 Cosmetic and /or pharmaceutical w/o emulsions comprising an alpha-omega oxyalkylated substituted silicone and a cotensioactive |
11/03/1999 | EP0953338A1 Packaging device for a product |
11/03/1999 | EP0953009A1 A process for preparing polymeric microgels |
11/03/1999 | EP0952873A1 Targeted hysteresis hyperthermia as a method for treating diseased tissue |
11/03/1999 | EP0952867A2 Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation |
11/03/1999 | EP0952855A1 Use of hyaluronan in gene therapy |
11/03/1999 | EP0952852A1 Stabilized hinokitiol and compositions containing same |
11/03/1999 | EP0952851A1 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
11/03/1999 | EP0952843A2 Pharmaceutical formulations for sustained drug delivery |
11/03/1999 | EP0952839A2 Green ointment |
11/03/1999 | EP0952837A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents |
11/03/1999 | EP0952831A1 Paroxetine compositions |
11/03/1999 | EP0952829A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
11/03/1999 | EP0952825A1 Patch carrying a particulate material and a magnet |
11/03/1999 | EP0952824A1 Enteric coating, comprising alginic acid, for an oral preparation |
11/03/1999 | EP0952823A1 Stabilized pharmaceutical compositions and process for the preparation thereof |
11/03/1999 | EP0952822A1 Chitosan-gelatin a microparticles |
11/03/1999 | EP0952821A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
11/03/1999 | EP0952820A1 Process for the manufacture of a pulverous preparation |
11/03/1999 | EP0952819A1 Biologically active composition |
11/03/1999 | EP0952812A1 Gel compositions containing gellants in the form of alkyl amides of tri-carboxylic acids |
11/03/1999 | EP0952807A2 Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products |
11/03/1999 | EP0952799A1 Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
11/03/1999 | EP0952770A1 System for rendering substantially non-dissoluble bio-affecting agents bio-available |
11/03/1999 | EP0859595B1 Therapeutic preparation for the transdermal administration of active substances |
11/03/1999 | EP0820521A4 Biological reagent spheres |
11/03/1999 | EP0820415B1 Method and apparatus for creating an aerosol mist |
11/03/1999 | EP0779807B1 Process of preparing a laminated tablet with pointed core |
11/03/1999 | EP0754033B1 Heterofunctional, mucoadhesive dosage form |
11/03/1999 | EP0744944B1 Sexual steroid-containing transdermal therapeutic systems |